TORTORA, Giampaolo
 Distribuzione geografica
Continente #
NA - Nord America 192
EU - Europa 113
AS - Asia 97
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 2
Totale 406
Nazione #
US - Stati Uniti d'America 191
CN - Cina 70
IT - Italia 48
IE - Irlanda 26
SE - Svezia 12
GB - Regno Unito 8
VN - Vietnam 6
FR - Francia 4
IR - Iran 4
NL - Olanda 4
AT - Austria 3
DE - Germania 3
HK - Hong Kong 3
IN - India 3
KR - Corea 3
AU - Australia 2
EU - Europa 2
FI - Finlandia 2
JP - Giappone 2
PH - Filippine 2
PL - Polonia 2
SG - Singapore 2
TW - Taiwan 2
CA - Canada 1
UA - Ucraina 1
Totale 406
Città #
Dublin 26
Chandler 15
Beijing 13
Fairfield 11
Chengdu 10
Nyköping 10
Torino 10
Medford 9
Woodbridge 9
Houston 8
Wilmington 8
New York 7
Princeton 7
Cambridge 6
Dong Ket 6
Guangzhou 6
Ashburn 5
Dearborn 5
Oxford 5
Seattle 5
Turin 5
Hangzhou 4
Pisa 4
Shanghai 4
Nanjing 3
Changchun 2
Hong Kong 2
Jinan 2
Kish 2
Lanzhou 2
Leeuwarden 2
Piemonte 2
Redwood City 2
San Diego 2
Santa Clara 2
Singapore 2
Taipei 2
Vienna 2
Villeurbanne 2
Warsaw 2
Zhengzhou 2
Ann Arbor 1
Aradeo 1
Berlin 1
Bovisio Masciago 1
Cairate 1
Casièr 1
Castagnaro 1
Digboi 1
Edinburgh 1
Genova 1
Guiyang 1
Helsinki 1
Hounslow 1
Kake 1
Kashan 1
Katy 1
Kunming 1
Köln 1
Lappeenranta 1
Leawood 1
Lexington 1
Los Angeles 1
Nanchang 1
Newcastle 1
Ningbo 1
North Brunswick 1
Norwalk 1
Ottawa 1
Rochester 1
Rome 1
Sandwich 1
Seoul 1
Shenyang 1
Shenzhen 1
Somma Lombardo 1
The Bronx 1
Tianjin 1
Venezia 1
Wuhan 1
Yinchuan 1
Yokohama 1
Totale 274
Nome #
Assessment of Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line chemotherapy in patients with advanced HER-2 negative gastric or gastroesophageal junction cancers: the ARMANI phase III trial 165
Lung neuroendocrine tumours: deep sequencing of the four World Health Organization histotypes reveals chromatin-remodelling genes as major players and a prognostic role for TERT, RB1, MEN1 and KMT2D 67
External Validation of a Prognostic Model for Squamous-Cell Lung Cancer and Impact of Adjuvant Treatment in >1,300 Patients: Topic: Neoadjuvant and Adjuvant Chemotherapy 44
Prognostic Model for Resected Squamous-Cell Lung Cancer: External Multicenter Validation and Propensity Score Analysis exploring the Impact of Adjuvant and Neoadjuvant Treatment. 40
De novo metastatic castration sensitive prostate cancer: State of art and future perspectives 32
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): a randomised, double-blind, phase 3 trial 28
The prognostic value of pain in castration-sensitive prostate cancer 25
First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin 22
Cultural adaptation of the Italian version of the Patient-Reported Outcomes Common Terminology Criteria for Adverse Event (PRO-CTCAE®) 3
Totale 426
Categoria #
all - tutte 1.549
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.549


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201912 0 0 0 0 0 0 0 0 0 3 9 0
2019/202073 4 3 2 13 1 12 9 8 6 4 7 4
2020/202172 7 5 6 3 1 8 7 4 5 7 4 15
2021/202282 8 3 5 4 5 3 2 3 5 4 25 15
2022/2023103 8 5 0 4 10 33 9 5 16 1 9 3
2023/202454 4 18 5 3 2 8 0 1 3 10 0 0
Totale 426